Denmark-based Xellia Pharmaceuticals is investing EUR 70.85 million in Szigetszentmiklós, south of Budapest, further strengthening Hungary’s role in the European healthcare and antibiotic supply chain. The development aims to create a modern, automated pharmaceutical manufacturing plant and promises create 91 new high value-added jobs. Headquartered in Copenhagen, Xellia Pharmaceuticals is a specialty pharmaceutical company focused […]
The post New Pharmaceutical Industry Investment in Hungary appeared first on Diplomacy & Trade.
